טוען...
Immunotherapeutic Strategies for High-Risk Bladder Cancer
Transitional cell carcinoma (TCC), which is the pathological diagnosis for the majority of bladder cancers, is a solid tumor entity that is responsive to immunotherapy as evidenced by a substantial cure rate documented with the use of intravesical bacillus Calmette-Guérin (BCG) therapy in selected p...
שמור ב:
| הוצא לאור ב: | Semin Oncol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2007
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6009830/ https://ncbi.nlm.nih.gov/pubmed/17382800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminoncol.2006.12.004 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|